**Core Concept**
Ketamine is an anesthetic agent that has bronchodilatory properties, making it an ideal choice in cases of status asthmaticus, where airway management is critical. This property allows for the relaxation of airway smooth muscles and improves ventilation in patients with severe asthma.

**Why the Correct Answer is Right**
Ketamine acts by blocking NMDA receptors in the brain, leading to sedation and analgesia. Its bronchodilatory effect is mediated through the inhibition of calcium channels in airway smooth muscle cells, causing relaxation and dilation of the airways. This makes ketamine an effective anesthetic agent in cases of status asthmaticus, where maintaining a patent airway is crucial. Additionally, ketamine's sympathomimetic properties help to maintain blood pressure and cardiac output, which is beneficial in patients with severe asthma.

**Why Each Wrong Option is Incorrect**
**Option A:** Thiopentone is a barbiturate anesthetic agent that can cause respiratory depression, which is contraindicated in status asthmaticus.
**Option B:** Ether is a volatile anesthetic agent that can irritate the airways and worsen bronchospasm in patients with asthma.
**Option C:** Nitrous oxide is a weak anesthetic agent that can also cause respiratory depression and is not suitable for use in status asthmaticus.
**Option D:** Ether is an outdated anesthetic agent with a high risk of airway irritation and is not suitable for use in status asthmaticus.

**Clinical Pearl / High-Yield Fact**
In cases of status asthmaticus, ketamine is often used as a first-line anesthetic agent due to its bronchodilatory properties and ability to maintain airway patency. However, it's essential to note that ketamine can cause increased salivation and airway secretion, which may require additional management.

✓ Correct Answer: A. Ketamine.